Skip to main content
Home / CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Volume 13, Number 2
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 2, 2014

Articles

Conference Report: 6th Clinical Trials on Alzheimer’s Disease (CTAD) Conference, Nov 14-16, 2013, The Westin San Diego Gaslamp Quarter Hotel, San Diego, CA, USA.
pp. 187-190(4)
Authors: S. Sharma, Hari; Sharma, Aruna; D. Skaper, Stephen

Favourites:
ADD

Free Content Commentary (Research Highlights: WNT-erizing Against Neuropathic Pain)
pp. 191-191(1)
Author: D. Skaper, Stephen

Favourites:
ADD

Free Content Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
pp. 192-196(5)
Author: Amjad Kamal, Mohammad

Favourites:
ADD

Exploring N1-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
pp. 197-202(6)
Authors: ul Ain, Qurrat; H. Greig, Nigel; S. Nawaz, Muhammad; Rashid, Sajid; A. Kamal, Mohammad

Favourites:
ADD

Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes
pp. 203-212(10)
Authors: Nedjadi, Taoufik; Haque, Absarul; Alam, Qamre; H. Gan, Siew; G. Chaudhary, Adeel; M. Abuzenadah, Adel; A. Damanhouri, Ghazi; A. Kamal, Mohammad

Favourites:
ADD

Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
pp. 213-225(13)
Authors: Mirza, Zeenat; Ali, Ashraf; Md. Ashraf, Ghulam; A. Kamal, Mohammad; M. Abuzenadah, Adel; G. Choudhary, Adeel; A. Damanhouri, Ghazi; A. Sheikh, Ishfaq

Favourites:
ADD

Autophagy Dysfunction and its Link to Alzheimer’s Disease and Type II Diabetes Mellitus
pp. 226-246(21)
Authors: M. Wilson, Cornelia; Magnaudeix, Amandine; Yardin, Catherine; Terro, Faraj

Favourites:
ADD

Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach
pp. 247-258(12)
Authors: Gauthaman, Kalamegam; Natesan Pushparaj, Peter; Rajeshkumar, Manoharan; Narasimhan, Kothandaraman; Al-Qahtani, Mohammed; Sang Cheung, Nam; Manikandan, Jayapal

Favourites:
ADD

Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus
pp. 259-264(6)
Authors: Haque, Rizwanul; Nazir, Aamir

Favourites:
ADD

A Neuroinformatics Study Describing Molecular Interaction of Cisplatin with Acetylcholinesterase: A Plausible Cause for Anticancer Drug Induced Neurotoxicity
pp. 265-270(6)
Authors: Hassan Baig, Mohd; Danish Rizvi, Syed Mohd.; Shakil, Shazi; Amjad Kamal, Mohammad; Khan, Saif

Favourites:
ADD

Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
pp. 271-282(12)
Authors: Dai, Ying; A. Kamal, Mohammad

Favourites:
ADD

Epigenomic Approach in Understanding Alzheimer’s Disease and Type 2 Diabetes Mellitus
pp. 283-289(7)
Authors: M. Shaik, Munvar; H. Gan, Siew; A. Kamal, Mohammad

Favourites:
ADD

Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects
pp. 290-298(9)
Authors: A. Dar, Tanveer; A. Sheikh, Ishfaq; A. Ganie, Showkat; Ali, Riyasat; R. Singh, Laishram; Hua Gan, Siew; A. Kamal, Mohammad; A. Zargar, Mohammad

Favourites:
ADD

Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting
pp. 299-304(6)
Authors: R. Jabir, Nasimudeen; A. Kamal, Mohammad; Mohammad Abuzenadah, Adel; Hua Gan, Siew; Nabil Alama, Mohammed; S. Baeesa, Saleh; Tabrez, Shams

Favourites:
ADD

Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
pp. 305-311(7)
Authors: I. Naseer, Muhammad; Bibi, Fehmida; H. Alqahtani, Mohammed; G. Chaudhary, Adeel; I. Azhar, Esam; A. Kamal, Mohammad; Yasir, Muhammad

Favourites:
ADD

A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease
pp. 312-321(10)
Authors: Ahmed, Firoz; Asghar Ansari, Juned; Eqbal Ansari, Zahid; Alam, Qamre; Hua Gan, Siew; A. Kamal, Mohammad; Ahmad, Ejaj

Favourites:
ADD

The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
pp. 322-337(16)
Authors: Zemva, Johanna; Schubert, Markus

Favourites:
ADD

Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
pp. 338-346(9)
Authors: A. Kamal, Mohammad; Priyamvada, Shubha; N. Anbazhagan, Arivarasu; R. Jabir, Nasimudeen; Tabrez, Shams; H. Greig, Nigel

Favourites:
ADD

Neuropeptides as Therapeutic Targets to Combat Stress-Associated Behavioral and Neuroendocrinological Effects
pp. 347-368(22)
Authors: Bali, Anjana; Singh, Nirmal; Singh Jaggi, Amteshwar

Favourites:
ADD

The Multiple Pharmaceutical Potential of Curcumin in Parkinson's Disease
pp. 369-373(5)
Authors: Ji, Hong-Fang; Shen, Liang

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content